Altogether, our data suggest the presence of cytotoxic c-Met+ CD8 clones derived from cancer patients, and these cells have a higher cytotoxic capacity compared to c-Met− CD8 clones, which is decreased upon in vitro treatment with hHGF. The gene discussed is CD8A; the disease is cancer.